PATENT CLAIM ANALYSIS

Application Number: 16063040
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.

Claim (Index 7):
The method of  claim 5 , wherein the subject has cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.15
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14527028', '13128046', '14355174', '14381362', '12740873']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6875216136757206
- 35 USC 102 Novelty (BERT): 0.52722945147505
- Combined Prediction Score: 0.6714923974556536
- Mean Citation Score: 232.418996
- Max Citation Score: 242.8346
- Similarity Product: 124.92975153255465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test